Heikki Joensuu

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 23

Top Topics

Early Breast Cancer

Abdominal Aortic Aneurysm

Top Venues

British journal of cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu, Annette Reichardt, Mikael Eriksson, Peter Hohenberger, Kjetil Boye, Silke Cameron, Lars H Lindner, Philipp J Jost, Sebastian Bauer, Jochen Schütte, Stefan Lindskog, Raija Kallio, Panu M Jaakkola, Dorota Goplen, Eva Wardelmann, Peter Reichardt
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial. British journal of cancer 131 (2) (2024)
Heikki Joensuu
KIT and PDGFRA Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib. Cancers 15 (15) (2023)
Heikki Joensuu, Eva Wardelmann, Mikael Eriksson, Annette Reichardt, Kirsten Sundby Hall, Jochen Schütte, Silke Cameron, Peter Hohenberger, Harri Jaakko Sihto, Philipp J Jost, Lars Hartwin Lindner, Sebastian Bauer, Bengt Nilsson, Raija Kallio, Tommi Pesonen, Peter Reichardt
KIT And PDGFRA Mutations And Survival of Gastrointestinal Stromal Tumor Patients Treated With Adjuvant Imatinib in a Randomized Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Maha H A Hussain, Bertrand Tombal, Fred Saad, Karim Fizazi, Cora N Sternberg, E David Crawford, Neal D Shore, Evgeny Kopyltsov, Arash Rezazadeh Kalebasty, Martin Boegemann, Dingwei Ye, Felipe José Silva Melo Cruz, Hiroyoshi Suzuki, Shivani Kapur, Shankar Srinivasan, Frank Verholen, Iris Kuss, Heikki Joensuu, Matthew R Smith
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Jodi M Carter, Saranya Chumsri, Douglas A Hinerfeld, Yaohua Ma, Xue Wang, David Zahrieh, David W Hillman, Kathleen S Tenner, Jennifer M Kachergus, Heather Ann Brauer, Sarah E Warren, David Henderson, Ji Shi, Yi Liu, Heikki Joensuu, Henrik Lindman, Roberto A Leon-Ferre, Judy C Boughey, Minetta C Liu, James N Ingle, Krishna R Kalari, Fergus J Couch, Keith L Knutson, Matthew P Goetz, Edith A Perez, E Aubrey Thompson
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer. Nature communications 14 (1) (2023)
Sherif Samer Attalla, Jonathan Boucher, Hailey Proud, Tarek Taifour, Dongmei Zuo, Virginie Sanguin-Gendreau, Chen Ling, Gabriella Johnson, Vincent Li, Robin B Luo, Hellen Kuasne, Vasilios Papavasiliou, Logan A Walsh, Mark Barok, Heikki Joensuu, Morag Park, Philippe P Roux, William J Muller
HER2∆16 Engages ENPP1 To Promote an Immune Cold Microenvironment in Breast Cancer. Cancer immunology research (2023)
Leonora W de Boo, Katarzyna Jóźwiak, Heikki Joensuu, Henrik Lindman, Susanna Lauttia, Mark Opdam, Charlaine van Steenis, Wim Brugman, Roelof J C Kluin, Philip C Schouten, Marleen Kok, Petra M Nederlof, Michael Hauptmann, Sabine C Linn
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients. British journal of cancer 126 (10) (2022)
Mari Karimaa, Reetta Riikonen, Henna Kettunen, Päivi Taavitsainen, Meri Ramela, Marcin Chrusciel, Stefan Karlsson, Petteri Rummakko, Outi Simola, Gerd Wohlfahrt, Pasi Hakulinen, Annamari Vuorela, Heikki Joensuu, Tapio Utriainen, Karim Fizazi, Riikka Oksala
First-in-Class Small Molecule to Inhibit CYP11A1 and Steroid Hormone Biosynthesis. Molecular cancer therapeutics 21 (12) (2022)
Heikki Joensuu, Pirkko Liisa Kellokumpu-Lehtinen, Riikka Huovinen, Arja Jukkola, Minna Tanner, Johan Ahlgren, Päivi Auvinen, Outi Lahdenperä, Kenneth Villman, Paul Nyandoto, Greger Nilsson, Paula Poikonen-Saksela, Vesa Kataja, Petri Bono, Jouni J T Junnila, Henrik Lindman
Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (10) (2022)
Sherene Loi, Roberto Salgado, Sylvia Adams, Giancarlo Pruneri, Prudence A Francis, Magali Lacroix-Triki, Heikki Joensuu, Maria Vittoria Dieci, Sunil S Badve, Sandra Demaria, Robert C Gray, Elisabetta Munzone, Damien Drubay, Jerome Lemonnier, Christos Sotiriou, Pirkko Liisa Kellokumpu-Lehtinen, Andrea Vingiani, Kathryn Gray, Fabrice Andre, Carsten Denkert, Martine Piccart, Elvire Roblin, Stefan Michiels
Tumor infiltrating lymphocyte stratification of prognostic staging of early-stage triple negative breast cancer. NPJ breast cancer 8 (1) (2022)
Olli-Pekka Pulkka, Leevi Viisanen, Olli Tynninen, Maria Laaksonen, Peter Reichardt, Annette Reichardt, Mikael Eriksson, Kirsten Sundby Hall, Eva Wardelmann, Bengt Nilsson, Harri Jaakko Sihto, Heikki Joensuu
Fibrinogen-like protein 2 in gastrointestinal stromal tumour. Journal of cellular and molecular medicine 26 (4) (2022)
Bruno Vincenzi, Andrea Napolitano, Marta Fiocco, Olivier Mir, Piotr Rutkowski, Jean Yves Blay, Peter Reichardt, Heikki Joensuu, Elena Fumagalli, Spyridon Gennatas, Nadia Hindi, Margherita Nannini, Mariella Spalato Ceruso, Antoine Italiano, Giovanni Grignani, Antonella Brunello, Silvia Gasperoni, Tommaso Martino De Pas, Giuseppe Badalamenti, Maria A Pantaleo, Winan J van Houdt, Nikki S IJzerman, Neeltje Steeghs, André B P van Kuilenburg, Ingrid M E Desar, Johanna Falkenhorst, Marianna Silletta, Marta Sbaraglia, Giuseppe Tonini, Javier Martín-Broto, Peter Hohenberger, Axel Le Cesne, Robin L Jones, Angelo Paolo Dei Tos, Alessandro Gronchi, Sebastian Bauer, Paolo G Casali
Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Pauliina M Munne, Lahja Martikainen, Iiris Räty, Kia Bertula, Nonappa Nonappa, Janika Ruuska, Hanna Ala-Hongisto, Aino Peura, Babette Hollmann, Liliya Euro, Kerim Yavuz, Linda Patrikainen, Maria Salmela, Juho Pokki, Mikko Kivento, Juho Väänänen, Tomi Suomi, Liina Nevalaita, Minna Mutka, Panu E Kovanen, Marjut Leidenius, Tuomo Meretoja, Katja Hukkinen, Outi Monni, Jeroen Pouwels, Biswajyoti Sahu, Johanna Mattson, Heikki Joensuu, Päivi Heikkilä, Laura L Elo, Ciara Metcalfe, Melissa R Junttila, Olli Ikkala, Juha Klefström
Compressive stress-mediated p38 activation required for ERα + phenotype in breast cancer. Nature communications 12 (1) (2021)
Karama Asleh, Heather Ann Brauer, Amy Sullivan, Susanna Lauttia, Henrik Lindman, Torsten O Nielsen, Heikki Joensuu, E Aubrey Thompson, Saranya Chumsri
Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (11) (2020)
Vadim Le Joncour, Ana Martins, Maija Puhka, Jorma Isola, Marko Salmikangas, Pirjo Laakkonen, Heikki Joensuu, Mark Barok
A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine. Molecular cancer therapeutics 18 (10) (2019)
Jeff Sperinde, Weidong Huang, Aki Vehtari, Ahmed Chenna, Pirkko Liisa Kellokumpu-Lehtinen, John Winslow, Petri Bono, Yolanda S Lie, Christos J Petropoulos, Jodi Weidler, Heikki Joensuu
p95HER2 Methionine 611 Carboxy-Terminal Fragment Is Predictive of Trastuzumab Adjuvant Treatment Benefit in the FinHer Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 24 (13) (2018)
Tatiana Lepikhova, Piia-Riitta Karhemo, Riku Louhimo, Bhagwan Yadav, Astrid Murumägi, Evgeny Kulesskiy, Mikko Kivento, Harri Jaakko Sihto, Reidar Grénman, Stina M Syrjänen, Olli Kallioniemi, Tero Aittokallio, Krister Wennerberg, Heikki Joensuu, Outi Monni
Drug-Sensitivity Screening and Genomic Characterization of 45 HPV-Negative Head and Neck Carcinoma Cell Lines for Novel Biomarkers of Drug Efficacy. Molecular cancer therapeutics 17 (9) (2018)
Riina Kaukonen, Anja Mai, Maria Georgiadou, Markku Saari, Nicola De Franceschi, Timo Betz, Harri Jaakko Sihto, Sami Ventelä, Laura Elo, Eija Jokitalo, Jukka Westermarck, Pirkko-Liisa Kellokumpu-Lehtinen, Heikki Joensuu, Reidar Grenman, Johanna Ivaska
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription. Nature communications 7 (2016)